rhabdomyosarcoma (Disease)

Id:DOID:3247

Description:A skeletal muscle cancer that arise from skeletal muscle progenitors.

Linked to

	Label	Description
	SKES1 Subject (Entity type)	A subject from LINCS produced as part of the LINCS project
	A673 Subject (Entity type)	A subject from LINCS produced as part of the LINCS project
	TC32 Subject (Entity type)	A subject from LINCS produced as part of the LINCS project
	L1000 LINCS DCIC 2021 MOAR011 SKES1 24H C19 delphinidin 10uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 MOAR011 SKES1 24H D04 captopril 10uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 CPC006 A673 6H A22 Y-27632 4uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 MOAR011 SKES1 24H G01 CPI-1189 10uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 MOAR012 SKES1 24H C03 tofogliflozin 1.11uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 ASG002 TC32 24H O03 crizotinib 0.08uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 MOAR012 SKES1 24H F21 darusentan 1.11uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project

SKES1

A subject from LINCS produced as part of the LINCS project

A673

A subject from LINCS produced as part of the LINCS project

TC32

A subject from LINCS produced as part of the LINCS project

L1000 LINCS DCIC 2021 MOAR011 SKES1 24H C19 delphinidin 10uM